CLINICAL_TRIALS
research
· 2026-02-02
Clinical Trial Update: A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer [Phase 3]
Summary
Phase 3 multicenter study evaluating OncoVax, an active specific immunotherapy, in patients with stage II colon cancer. The trial status is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vaccinogen Inc | Conditions: Stage II Colon Cancer | Phase 3 | Status: NOT_YET_RECRUITING